Advancing Eye Health: Perceive Pharma Secures $15M Investment Boost
In addition, Perceive Pharma announced that Carol Gallagher, Pharm.D. has joined the company’s Board of Directors as an independent director.
February 18, 2025
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
In addition, Perceive Pharma announced that Carol Gallagher, Pharm.D. has joined the company’s Board of Directors as an independent director.
This financing includes investments from new investors Longevity Venture Partners, Tech Council Ventures, and Edge Medical Ventures, alongside participation from existing investors notes Exero Medical.
“With the support of our world-class partners, we are thrilled to enter the next phase of clinical and industrial development,” said Amaury Ciurana, Co-Founder and CEO of REEV. “Our innovative technologies, like the DREEVEN motorized orthosis, aim to redefine mobility assistance, transforming lives and reshaping the orthotics industry.”